AI Content Chat (Beta) logo

Introduction Transforming care Investing in our people Accelerating possibilities Protecting the environment Creating value responsibly Appendix Investing in our people Diversity and inclusion Unit 2018 2019 2020 2021 2022 1 Representation of women (globally) Board of Directors — women Percent 30.0 30.0 30.0 30.0 30.02 3 Executive officers — women Percent 18.8 25.0 25.0 18.8 11.1 4 Executive Committee — women Percent 18.8 25.0 25.0 18.8 25.0 5 Senior management — women Percent 29.5 31.0 33.2 34.8 37.7 6 Supervisors and managers — women Percent 38.4 38.1 39.9 41.1 42.6 Share of total field sales management positions — women Percent 22.0 21.3 22.9 24.1 26.8 Share of total workforce — women Percent 46.5 47.0 47.4 48.3 49.0 New hires — women Percent 51.2 50.2 48.9 51.7 51.8 Women by region United States, including Puerto Rico Percent 44.3 45.0 45.3 46.8 47.7 Latin America Percent 57.7 56.1 55.7 55.6 55.2 Canada Percent 43.6 43.4 48.1 48.4 48.8 Europe, Middle East and Africa Percent 45.5 45.5 46.3 47.0 47.1 Asia Pacific Percent 43.3 46.4 46.9 46.5 49.2 1 Gender: includes all employees globally where gender is identified. Excludes any employees where gender is "undeclared" and "unknown." 2 Donna James will remain in her role as a director of the Company until her resignation becomes effective on the day of the 2023 Annual Meeting of Stockholders, which is scheduled to occur on May 4, 2023. 3 Executive officers: includes all executive officers listed in the Annual Report. 4 Executive Committee: includes all Executive Committee members as of December 31 of that calendar year. 5 Senior management: includes all levels that are director, vice president, senior vice president, executive vice president and CEO. 6 Supervisors and managers: includes all levels that are supervisor, manager I and manager II. 60 2022 Performance Report

Advancing Science for Life | Boston Scientific - Page 60 Advancing Science for Life | Boston Scientific Page 59 Page 61